Immunohistochemistry in gynecological pathology

International Journal of Gynecological Cancer

Volumn 13, Issue 5, 2003, Pages 567-579

  Deavers, Michael T ^a   Malpica, A ^a   Silva, E G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cervical neoplasms; Immunohistochemistry; Ovarian neoplasms; Uterine neoplasms; Vaginal neoplasms; Vulvar neoplasms

Indexed keywords

BIOCHEMICAL MARKER; CD45 ANTIGEN; EOSIN; HEMATOXYLIN; KERATIN; PROTEIN S 100; VIMENTIN;

ADENOCARCINOMA; BENIGN TUMOR; CARCINOMA IN SITU; DIFFERENTIAL DIAGNOSIS; ENDOMETRIAL STROMAL TUMOR; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; GERM CELL TUMOR; GYNECOLOGIC DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MESOTHELIOMA; MUSCLE TUMOR; NEUROENDOCRINE TUMOR; OVARY CARCINOMA; OVARY MESOTHELIOMA; OVARY METASTASIS; OVARY SEROUS CARCINOMA; PAGET SKIN DISEASE; PRIORITY JOURNAL; REVIEW; RHABDOMYOSARCOMA; SARCOMA; SEX CORD TUMOR; SQUAMOUS CELL CARCINOMA; STAINING; TECHNIQUE; TROPHOBLASTIC TUMOR; UTERINE CERVIX CARCINOMA IN SITU; UTERUS CARCINOMA; UTERUS SEROUS CARCINOMA; VAGINA CANCER; VAGINA CARCINOMA; VAGINA SARCOMA; VULVA CANCER; VULVA INTRAEPITHELIAL NEOPLASIA;

FEMALE; GENITAL NEOPLASMS, FEMALE; GYNECOLOGY; HUMANS; IMMUNOHISTOCHEMISTRY;

EID: 1242269317     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2003.13387.x     Document Type: Review

References (63)

1. Bratthauer GL, Adams LR. Immunohistochemistry: antigen detection in tissue. In: Mikel, UV, ed. Advanced Laboratory Methods in Histology and Pathology. Washington, DC: Armed Forces Institute of Pathology, 1994; 1-40.
2. Battles OE, Page DL, Johnson JE. Cytokeratins, CEA, and mucin histochemistry in the diagnosis and characterization of extramammary Paget's disease. Am J Clin Pathol 1997;108:6-12.
3. Goldblum JR, Hart WR. Vulvar Paget's disease, a clinicopathologic and immunohistochemical study of 19 cases. Am J Surg Pathol 1997;21:1178-87.
4. Bacchi CE, Goldfogel GA, Greer BE, Gown AM. Paget's disease and melanoma of the vulva. Use of a panel of monoclonal antibodies to identify cell type and to microscopically define adequacy of surgical margins. Gynecol Oncol 1992;46:216-21.
5. Brainard JA, Hart WR. Proliferative epidermal lesions associated with anogenital Paget's disease. Am J Surg Pathol 2000;24:543-52.
6. Nowak MA, Guerriere-Kovach P, Pathan A, Campbell TE, Deppisch LM. Perianal Paget's disease. Distinguishing primary and secondary lesions using immunohistochemical studies including gross cystic disease fluid protein-15 and cytokeratin 20 expression. Arch Pathol Lab Med 1998;122:1077-81.
7. Yang B, Hart WR. Vulvar intraepithelial neoplasia of the simplex (differentiated) type. A clinicopathologic study including analysis of HPV and p53 expression. Am J Surg Pathol 2000;24:429-41.
8. Rollason TP, Byrne P, Williams A. Immunohistochemical and electron microscopic findings in benign fibroepithelial vaginal polyps. J Clin Pathol 1990;43:224-9.
9. Nucci MR, Young RH, Fletcher CDM. Cellular pseudosarcomatous fibroepithelial stromal polyps of the lower female genital tract: an under recognized lesion often misdiagnosed as sarcoma. Am J Surg Pathol 2000;24:231-40.
10. McCluggage WG, Buhidma M, Tang L, Maxwell P, Bharucha H. Monoclonal antibody MIB1 in the assessment of cervical squamous intraepithelial lesions. Int J Gynecol Pathol 1996;15:131-6.
11. Mittal K. Utility of proliferation-associated marker MIB1 in evaluating lesions of the uterine cervix. Adv Anat Pathol 1999;6:177-85.
12. INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001;25:884-91.
13. INK4A immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002;26:1389-99.
14. Michael H, Grawe L, Kraus Fr. Minimal deviation endocervical adenocarcinoma. Clinical and histologic features, immunohistochemical staining for carcinoembryonic antigen, and differentiation from confusing benign lesions. Int J Gynecol Pathol 1984;3:261-76.
15. Gilks CB, Young RH, Aguirre P, DeLellis RA, Scully RE. Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases. Am J Surg Pathol 1989;13:717-29.
16. Lesack D, Wahab I, Gilks CB. Radiation-induced atypia of endocervical epithelium: a histological, immunohistochemical and cytometric study. Int J Gynecol Pathol 1996;15:242-7.
17. Cina SJ, Richardson MS, Austin RM, Kurman RJ. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. Mod Pathol 1997;10:176-80.
18. Parker MF, Arroyo GF, Geradts J et al. Molecular characterization of adenocarcinoma of the cervix. Gynecol Oncol 1997;64:242-51.
19. INK4A, and early endocervical glandular neoplasia. Hum Pathol 2002;33:899-904.
20. ink4A is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors. An immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol 2003;27: 187-93.
21. Wahlstrom T, Lindgren J, Korhonen M, Seppala M. Distinction between endocervical and endometrial adenocarcinoma with immunoperoxidase staining of carcinoembryonic antigen in routine histological tissue specimens. Lancet 1979;2:1159-60.
22. Cohen C, Shulman G, Budgeon LR. Endocervical and endometrial adenocarcinoma. An immunoperoxidase and histochemical study. Am J Surg Pathol 1982;6:151-7.
23. Dabbs DJ, Geisinger KR, Norris HT. Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns. Am J Surg Pathol 1986;10:568-76.
24. Dabbs DJ, Sturtz K, Zaino RJ. The immunohistochemical discrimination of endometrioid adenocarcinomas. Hum Pathol 1996;27:172-7.
25. Albores-Saavedra J, Gersell D, Gilks CB et al. Terminology of endocrine tumors of the uterine cervix. Results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute. Arch Pathol Lab Med 1997;121:34-9.
26. Kaufmann O, Georgi T, Dietel M. Utility of 123C3 monoclonal antibody against CD56 (NCAM) for the diagnosis of small cell carcinomas on paraffin sections. Hum Pathol 1997;28:1373-8.
27. Sherman ME, Bur ME, Kurman RJ. P53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol 1995;26:1268-74.
28. Kounelis S, Kapranos N, Kouri E, Coppola D, Papadaki H, Jones MW. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature. Mod Pathol 2000;13:379-88.
29. Schlosshauer PW, Ellenson LH, Soslow RA. β-catenin and E-cadherin expression patterns in high grade endometrial carcinoma are associated with histological subtype. Mod Pathol 2002;15:1032-7.
30. Quddus MR, Sung CJ, Zheng W, Lauchlan SC. p53 immunoreactivity in endometrial metaplasia with dysfunctional uterine bleeding. Histopathology 1999;35:44-9.
31. Chu P, Arber DA. Paraffin-section detection of CD10 in 505 non-hematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol 2000;113:374-82.
32. Rush DS, Tan J, Baergen RN, Soslow RA. h-caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Am J Surg Pathol 2001;25:253-8.
33. Oliva E, Young RH, Amin MB, Clement PB. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus. A study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies. Am J Surg Pathol 2002;26:403-12.
34. Zhai YL, Kobayashi Y, Mori A et al. Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas. Int J Gynecol Pathol 1999;18:20-8.
35. Hameed A, Miller DS, Muller CY, Coleman RL, Albores-Saavedra J. Frequent expression of β-human chorionic gonadotropin (β-HCG) in squamous cell carcinoma of the cervix. Int J Gynecol Pathol 1999;18:381-6.
36. Kurman RJ, Young RH, Norris HJ, Main CS, Lawrence DW, Scully RE. Immunocytochemical localization of placental lactogen and chorionic gonadotropin in the normal placenta and trophoblastic tumors, with emphasis on intermediate trophoblast and the placental site trophoblastic tumor. Int J Gynecol Pathol 1984;3:101-21.
37. Shih IM, Kurman RJ. Immunohistochemical localization of inhibin-α in the placenta and gestational trophoblastic lesions. Int J Gynecol Pathol 1999;18:144-50.
38. Shih IM, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol 2001;20:31-47.
39. Ordonez NG. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas. Am J Surg Pathol 1998;22:1203-14.
40. Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 1995;3:99-107.
41. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000;13:962-72.
42. Kende AI, Carr NJ, Sobin LH. Expression of cytokeratins 7 and 20 in carcinomas of the gastrointestinal tract. Histopathology 2003;42:137-40.
43. Hoerl HD, Hart WR. Primary ovarian mucinous cystadenocarcinomas. A clinicopathologic study of 49 cases with long term follow-up. Am J Surg Pathol 1998; 22: 1449-62.
44. Shimizu M, Toki T, Takagi Y, Konishi I, Fujii S. Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors. Int J Gynecol Pathol 2000;19:158-63.
45. Goldstein NS, Bassi D, Uzieblo A. WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms. Am J Clin Pathol 2001;116:246-52.
46. Lee BH, Hecht JL, Pinkus JL, Pinkus GS. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids. Am J Clin Pathol 2002;117:745-50.
47. Mazoujian G, Pinkus GS, Davis S, Haagensen DE Jr. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Am J Pathol 1983;110:105-12.
48. Wick MR, Lillemoe TJ, Copland GT, Swanson PE, Manivel JC, Kiang DT. Gross cystic disease fluid protein-15 as a marker for breast cancer. Immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol 1989;20:281-7.
49. Ordonez NG. Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and non-pulmonary adenocarcinoma. Am J Surg Pathol 2000;24:598-606.
50. Loyt TS, Quesenberry JT, Sharp SC. Distribution of CA125 in adenocarcinomas. An immunohistochemical study of 481 cases. Am J Clin Pathol 1992;98:175-9.
51. Costa MJ, Ames PF, Walls J, Roth LM. Inhibin immunohistochemistry applied to ovarian neoplasms: a novel, effective, diagnostic tool. Hum Pathol 1997;28: 1247-54.
52. Rishi M, Howard LH, Bratthauer GL, Tavassoli FA. Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol 1997;21:583-9.
53. Movahedi-Lankarani S, Kurman RJ. Calretinin, a more sensitive but less specific marker than α-inhibin for ovarian sex cord-stromal neoplasms. An immunohistochemical study of 215 cases. Am J Surg Pathol 2002;26: 1477-83.
54. Deavers MT, Malpica A, Liu J, Broaddus R, Silva EG. Ovarian sex cord-stromal tumors, an imnumohistochemical study including a comparison of calretinin and inhibin. Mod Pathol 2003;16:584-90.
55. Wick MR, Swanson PE, Manivel JC. Placental-like alkaline phosphatase reactivity in human tumors, an immunohistochemical study of 520 cases. Hum Pathol 1987;18:946-54.
56. Niehans GA, Manivel JC, Copland GT, Scheithauer BW, Wick MR. Immunohistochemistry of germ cell and trophoblastic neoplasms. Cancer 1988;62:1113-23.
57. Zirker TA, Silva EG, Morris M, Ordonez NG. Immunohistochemical differentiation of clear cell carcinoma of the female genital tract and endodermal sinus tumor with the use of alpha-fetoprotein and Leu-M1. Am J Clin Pathol 1989;91:511-4.
58. Ramalingam P, Malpica A, Silva EG, Gershenson DM, Deavers MT. The use of cytokeratin 7 in differentiating yolk sac tumors from endometrioid and clear cell carcinomas of the ovary. Mod Pathol 2003;16:207A.
59. Pallesen G, Hamilton-Dutoit SJ. Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma. Am J Pathol 1988;133:446-50.
60. Mohabeer J, Buckley CH, Fox H. An imnumohistochemical study of the incidence and significance of human chorionic gonadotrophin synthesis by epithelial ovarian neoplasms. Gynecol Oncol 1983;16:78-84.
61. Vang R, Medeiros LJ, Fuller GN, Saris AH, Deavers M. Non-Hodgkin's lymphoma involving the gynecologic tract, a review of 88 cases. Adv Anat Pathol 2001;8:200-17.
62. Yang F, Tran TA, Carlson JA, Hsi ED, Ross CW, Arber DA. Paraffin section immunophenotype of cutaneous and extracutaneous mast cell disease. Comparison to other hematopoietic neoplasms. Am J Surg Pathol 2000; 24:703-9.
63. Chen J, Yanuck RR 3rd, Abbondanzo SL, Chu WS, Aguilera NSI. c-kit (CD117) reactivity in extramedullary myeloid tumor/granulocytic sarcoma. Arch Pathol Lab Med 2001; 125:1448-52.